IXICO plc (AIM:IXI)

Market Cap	7.30M
Revenue (ttm)	5.77M
Net Income (ttm)	-2.00M
Shares Out	92.67M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58,815
Average Volume	37,271
Open	8.00
Previous Close	7.88
Day's Range	7.75 - 8.98
52-Week Range	6.45 - 13.00
Beta	0.65
RSI	23.02
Earnings Date	May 20, 2025

About IXICO

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 81
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: IXI

Financial Performance

In 2024, IXICO's revenue was 5.77 million, a decrease of -13.49% compared to the previous year's 6.67 million. Losses were -2.00 million, 69.9% more than in 2023.